Literature DB >> 30554522

Caregiver versus self-reported activities of daily living among HIV-positive persons in Rakai, Uganda.

Alice Kisakye1, Deanna Saylor2, Ned Sacktor2, Gertrude Nakigozi1, Noeline Nakasujja3, Kevin Robertson4, Aggrey Anok1, Maria Wawer1,5, Ron Gray1,5.   

Abstract

Assessment of an individual's functional status, as measured by activities of daily living (ADL), is an essential element in the diagnosis of HIV-associated neurocognitive disorders (HAND) but individuals with cognitive impairment may not accurately report ADL. We assessed agreement between self- and caregiver-reported ADL in HIV-positive persons. Antiretroviral therapy (ART)-naïve HIV-positive persons (n = 321) and HIV-negative controls (n = 134) in Rakai, Uganda, completed neurocognitive tests and an ADL questionnaire. Co-resident relatives ("caregivers") were independently administered the ADL questionnaire to determine their perception of the participant's ADL. The relationship between neurocognitive impairment and participant-caregiver agreement was assessed using kappa statistics. Regression was used to estimate adjusted prevalence ratios (AdjPR) of participant-caregiver agreement on disability scores. Relative to HIV-negative adults, HIV-positive participants scoring at least 1 standard deviation (SD) below the norm on 2 or more neurocognitive tests were classified as having mild neurocognitive impairment and those scoring at least 2 SD below the norm on 2 or more neurocognitive tests were classified as having moderate-to-severe. Mean age was 36 years (SD 8.9), and 53% of participants were male. The rate of ADL agreement between participants and caregivers was 77% for HIV-positive and 87% for HIV-negative participants (AdjPR = 0.89, 95% CI 0.81-0.97, p = .01). Among HIV-positive participants, 41% had moderate neurocognitive impairment, 15% had severe neurocognitive impairment, and 44% were normal. For moderate neurocognitive impairment, the rate of ADL agreement was 69% and for severe neurocognitive impairment, it was 66%. Compared to non-impaired HIV-positive participants (86% ADL agreement), ADL agreement was lower with moderate impairment (AdjPR = 0.89, 95%CI 0.81-0.98, p = .023) and severe impairment (AdjPR = 0.77, 95%CI 0.63-0.95, p = .014). Gender, education and CD4 count were not associated with ADL agreement. HIV-positive persons with neurocognitive impairment have lower agreement with caregivers' reports of ADL than HIV-positive persons without cognitive impairment.

Entities:  

Keywords:  Activities of daily living; agreement; care giver; neurocognitive impairment; self-reports

Mesh:

Year:  2018        PMID: 30554522      PMCID: PMC6510610          DOI: 10.1080/09540121.2018.1557591

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  16 in total

Review 1.  Patient adherence to HIV medication regimens: a review of published and abstract reports.

Authors:  Linda Fogarty; Debra Roter; Susan Larson; Jessica Burke; Jeanne Gillespie; Richard Levy
Journal:  Patient Educ Couns       Date:  2002-02

2.  Updated research nosology for HIV-associated neurocognitive disorders.

Authors:  A Antinori; G Arendt; J T Becker; B J Brew; D A Byrd; M Cherner; D B Clifford; P Cinque; L G Epstein; K Goodkin; M Gisslen; I Grant; R K Heaton; J Joseph; K Marder; C M Marra; J C McArthur; M Nunn; R W Price; L Pulliam; K R Robertson; N Sacktor; V Valcour; V E Wojna
Journal:  Neurology       Date:  2007-10-03       Impact factor: 9.910

3.  Predicting and monitoring antiretroviral adherence.

Authors:  Robert Gross
Journal:  LDI Issue Brief       Date:  2007 Nov-Dec

4.  A revised activities of daily living/instrumental activities of daily living instrument increases interpretive power: theoretical application for functional tasks exercise.

Authors:  Robert Fieo; Roger Watson; Ian J Deary; John M Starr
Journal:  Gerontology       Date:  2009-12-23       Impact factor: 5.140

5.  Odds Ratios-Current Best Practice and Use.

Authors:  Edward C Norton; Bryan E Dowd; Matthew L Maciejewski
Journal:  JAMA       Date:  2018-07-03       Impact factor: 56.272

6.  Diagnosing symptomatic HIV-associated neurocognitive disorders: self-report versus performance-based assessment of everyday functioning.

Authors:  K Blackstone; D J Moore; R K Heaton; D R Franklin; S P Woods; D B Clifford; A C Collier; C M Marra; B B Gelman; J C McArthur; S Morgello; D M Simpson; M Rivera-Mindt; R Deutsch; R J Ellis; J Hampton Atkinson; I Grant
Journal:  J Int Neuropsychol Soc       Date:  2011-11-24       Impact factor: 2.892

7.  Concordance Between Self-Report and Performance-Based Measures of Everyday Functioning in HIV-Associated Neurocognitive Disorders.

Authors:  Talia N Shirazi; Angela C Summers; Bryan R Smith; Sally R Steinbach; Suad Kapetanovic; Avindra Nath; Joseph Snow
Journal:  AIDS Behav       Date:  2017-07

8.  The impact of HIV-associated neuropsychological impairment on everyday functioning.

Authors:  Robert K Heaton; Thomas D Marcotte; Monica Rivera Mindt; Joseph Sadek; David J Moore; Heather Bentley; J Allen McCutchan; Carla Reicks; Igor Grant
Journal:  J Int Neuropsychol Soc       Date:  2004-05       Impact factor: 2.892

9.  Patient-rated versus proxy-rated cognitive and functional measures in older adults.

Authors:  Molly Howland; Kevin C Allan; Caitlin E Carlton; Curtis Tatsuoka; Kathleen A Smyth; Martha Sajatovic
Journal:  Patient Relat Outcome Meas       Date:  2017-03-15

10.  Self-Reported Decline in Everyday Function, Cognitive Symptoms, and Cognitive Function in People With HIV.

Authors:  Rosanna Laverick; Lewis Haddow; Marina Daskalopoulou; Fiona Lampe; Richard Gilson; Andrew Speakman; Andrea Antinori; Tina Bruun; Anna Vassilenko; Simon Collins; Alison Rodger
Journal:  J Acquir Immune Defic Syndr       Date:  2017-11-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.